Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The Italian company Angelini Pharma ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

RESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England--(BUSINESS WIRE)--Worldwide Clinical Trials (“Worldwide” or the “Company”), a global contract research organization (CRO), has completed its ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The Tomb Raider franchise is one of the most prolific and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Bilateral heterogenous emphysema was the most comment presentation in patients referred for bronchoscopic lung volume reduction (BLVR), based on data from more than 200 individuals presented at the ...

The digital landscape is evolving at an unprecedented pace. From smartphones and wearables to autonomous vehicles and hyperscale data centers, the demand for faster, smarter, and more efficient ...

A team from Forschungszentrum Jülich and RWTH Aachen University has developed a novel approach for a catalyst that combines the advantages of the two most commonly used catalysis methods. The new ...